JDJonas Dippel

Jonas Dippel

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Jonas Dippel has a total of 41 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Top Cited Papers
    Open Access

    Towards robust foundation models for digital pathology

    by Jonah Kömen, Edwin D. de Jong, Julius Hense, Hannah Marienwald, Jonas Dippel, Philip Naumann, Eric Marcus, Lukas Ruff, Maximilian Alber, Jonas Teuwen, et al.

    Biomedical Foundation Models (FMs) are transforming AI-enabled healthcare research and entering clinical validation. However, their susceptibility to learning non-biological features — including variations in laboratory procedures and scanner hardware — poses risks for clinical deployment. We introduce PathoROB, a public benchmark quantifying FM robustness to non-biological features. Representation-level robustness is assessed using the robustness index, while output-level robustness is evaluated across clinically relevant settings, including patch- and slide-level prediction, case retrieval, and clustering tasks. Our experiments reveal robustness deficits across all 20 evaluated FMs, with substantial differences between them. We find that non-robust FM representations can cause major diagnostic downstream errors preventing safe clinical adoption. Using more robust FMs, vision-language alignment, and post-hoc robustification reduces (but does not yet eliminate) the risk of such errors. This work establishes that robustness evaluation is essential for validating pathology FMs before clinical adoption and provides a blueprint for assessing and improving robustness across biomedical domains.


  • Open Access

    Beyond attention heatmaps: How to get better explanations for multiple instance learning models in histopathology

    by Mina Jamshidi Idaji, Julius Hense, Tom Neuhäuser, Augustin Krause, Yanqing Luo, Oliver Eberle, Thomas Schnake, Laure Ciernik, Farnoush Rezaei Jafari, Reza Vahidimajd, et al.


  • Open Access

    Digital Spatial Pathway Mapping Reveals Prognostic Tumor States in Head and Neck Cancer

    by Julius Hense, Mina Jamshidi Idaji, Laure Ciernik, Jonas Dippel, Fatma Ersan, Maximilian Knebel, Ada Pusztai, Andrea Sendelhofert, Oliver Buchstab, Stefan Fröhling, et al.

    Head and neck squamous cell carcinoma (HNSCC) is a morphologically and molecularly heterogeneous disease with limited effectiveness of genotype-informed therapies. Transcriptome-derived estimates of signaling pathway activity carry prognostic and therapeutic potential but remain inaccessible in routine diagnostics due to cost and tissue constraints. Here, we introduce Digital Spatial Pathway Mapping , an AI-based computational pathology framework that infers signaling pathway activities directly from routine hematoxylin and eosin (H&E) slides, enabling in-silico spatial molecular readouts from standard histology. Models trained on HPV-negative HNSCC from TCGA and externally validated on CPTAC robustly predicted transcriptome-derived activities in cancer-relevant signaling pathways. To achieve spatial interpretability, we applied layer-wise relevance propagation (LRP) to generate heatmaps that highlight positive versus negative evidence for pathway activation. These LRP heatmaps were technically validated by patch-flipping tests and biologically validated against pathway-relevant immunohistochemistry in an independent patient cohort. From these explanations, we derived a tumor area pathway activity score (TAPAS) quantifying the spatial fraction of activated tumor regions within a slide. Applied to a retrospective HNSCC cohort of 1,066 slides from 112 resection specimens, TAPAS captured intratumoral heterogeneity and revealed two biologically dis-tinct tumor states - an oncogenic growth phenotype with widespread pathway activation and a pathway quiescent phenotype associated with higher recurrence risk independent of clinicopathological variables. These findings establish Digital Spatial Pathway Mapping as a scalable, in-silico approach to recover systems-level molecular information from standard histopathology, enabling prognostic and mechanistically grounded patient stratification in head and neck cancer.

  • AI-Based Anomaly Detection for Clinical-Grade Histopathological Diagnostics

    by Jonas Dippel, Niklas Prenißl, Julius Hense, Philipp Liznerski, Tobias Winterhoff, Simon Schallenberg, Marius Kloft, Oliver Buchstab, David Horst, Maximilian Alber, et al.